Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer

Maria E. Cabanillas; Michelle D. Williams; G. Brandon Gunn; Steven P. Weitzman; Laura Burke; Naifa L. Busaidy; Anita K. Ying; Yeh Hung Yiin; William N. William; Charles Lu; Stephen Y. Lai

doi:10.1002/hed.24784

Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer

Maria E. Cabanillas, Michelle D. Williams, G. Brandon Gunn, Steven P. Weitzman, Laura Burke, Naifa L. Busaidy, Anita K. Ying, Yeh Hung Yiin, William N. William, Charles Lu, Stephen Y. Lai

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Abstract

Background: Anaplastic thyroid cancer (ATC) is a highly aggressive thyroid cancer. Several treatment trials are available, but the number of eligible patients to participate is very low because of the rarity and aggressiveness of the disease. Methods: Facilitating Anaplastic Thyroid Cancer Specialized Treatment (FAST) is a quality improvement project aimed at decreasing time from referral to disposition (scheduling of first appointment) to our institution. After identifying reasons for delays, we created a new process flow specifically for patients with ATC allowing patients to be scheduled immediately. Results: Historical data revealed a mean referral to disposition time for patients with ATC of 8.7 days before our intervention. After the intervention, the mean referral to disposition time was reduced to 0.5 days. Participation in treatment trials for all patients with ATC was 34%. Conclusion: Since the implementation of FAST, the access time has decreased and the number of successful referrals for ATC has increased significantly.

Original language	English (US)
Pages (from-to)	1291-1295
Number of pages	5
Journal	Head and Neck
Volume	39
Issue number	7
DOIs	https://doi.org/10.1002/hed.24784
State	Published - Jul 2017

Keywords

anaplastic thyroid carcinoma
clinical trials
multidisciplinary care
quality improvement
thyroid cancer

ASJC Scopus subject areas

Otorhinolaryngology

Access to Document

10.1002/hed.24784

Cite this

Cabanillas, M. E., Williams, M. D., Gunn, G. B., Weitzman, S. P., Burke, L., Busaidy, N. L., Ying, A. K., Yiin, Y. H., William, W. N., Lu, C., & Lai, S. Y. (2017). Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer. Head and Neck, 39(7), 1291-1295. https://doi.org/10.1002/hed.24784

Cabanillas, ME , Williams, MD , Gunn, GB , Weitzman, SP, Burke, L, Busaidy, NL , Ying, AK, Yiin, YH, William, WN, Lu, C & Lai, SY 2017, 'Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer', Head and Neck, vol. 39, no. 7, pp. 1291-1295. https://doi.org/10.1002/hed.24784

@article{dead3abaae2b455689634116b4717406,

title = "Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer",

abstract = "Background: Anaplastic thyroid cancer (ATC) is a highly aggressive thyroid cancer. Several treatment trials are available, but the number of eligible patients to participate is very low because of the rarity and aggressiveness of the disease. Methods: Facilitating Anaplastic Thyroid Cancer Specialized Treatment (FAST) is a quality improvement project aimed at decreasing time from referral to disposition (scheduling of first appointment) to our institution. After identifying reasons for delays, we created a new process flow specifically for patients with ATC allowing patients to be scheduled immediately. Results: Historical data revealed a mean referral to disposition time for patients with ATC of 8.7 days before our intervention. After the intervention, the mean referral to disposition time was reduced to 0.5 days. Participation in treatment trials for all patients with ATC was 34%. Conclusion: Since the implementation of FAST, the access time has decreased and the number of successful referrals for ATC has increased significantly.",

keywords = "anaplastic thyroid carcinoma, clinical trials, multidisciplinary care, quality improvement, thyroid cancer",

author = "Cabanillas, {Maria E.} and Williams, {Michelle D.} and Gunn, {G. Brandon} and Weitzman, {Steven P.} and Laura Burke and Busaidy, {Naifa L.} and Ying, {Anita K.} and Yiin, {Yeh Hung} and William, {William N.} and Charles Lu and Lai, {Stephen Y.}",

note = "Publisher Copyright: {\textcopyright} 2017 Wiley Periodicals, Inc.",

year = "2017",

month = jul,

doi = "10.1002/hed.24784",

language = "English (US)",

volume = "39",

pages = "1291--1295",

journal = "Head and Neck",

issn = "1043-3074",

publisher = "Wiley-Liss Inc.",

number = "7",

}

TY - JOUR

T1 - Facilitating anaplastic thyroid cancer specialized treatment

T2 - A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer

AU - Cabanillas, Maria E.

AU - Williams, Michelle D.

AU - Gunn, G. Brandon

AU - Weitzman, Steven P.

AU - Burke, Laura

AU - Busaidy, Naifa L.

AU - Ying, Anita K.

AU - Yiin, Yeh Hung

AU - William, William N.

AU - Lu, Charles

AU - Lai, Stephen Y.

PY - 2017/7

Y1 - 2017/7

N2 - Background: Anaplastic thyroid cancer (ATC) is a highly aggressive thyroid cancer. Several treatment trials are available, but the number of eligible patients to participate is very low because of the rarity and aggressiveness of the disease. Methods: Facilitating Anaplastic Thyroid Cancer Specialized Treatment (FAST) is a quality improvement project aimed at decreasing time from referral to disposition (scheduling of first appointment) to our institution. After identifying reasons for delays, we created a new process flow specifically for patients with ATC allowing patients to be scheduled immediately. Results: Historical data revealed a mean referral to disposition time for patients with ATC of 8.7 days before our intervention. After the intervention, the mean referral to disposition time was reduced to 0.5 days. Participation in treatment trials for all patients with ATC was 34%. Conclusion: Since the implementation of FAST, the access time has decreased and the number of successful referrals for ATC has increased significantly.

AB - Background: Anaplastic thyroid cancer (ATC) is a highly aggressive thyroid cancer. Several treatment trials are available, but the number of eligible patients to participate is very low because of the rarity and aggressiveness of the disease. Methods: Facilitating Anaplastic Thyroid Cancer Specialized Treatment (FAST) is a quality improvement project aimed at decreasing time from referral to disposition (scheduling of first appointment) to our institution. After identifying reasons for delays, we created a new process flow specifically for patients with ATC allowing patients to be scheduled immediately. Results: Historical data revealed a mean referral to disposition time for patients with ATC of 8.7 days before our intervention. After the intervention, the mean referral to disposition time was reduced to 0.5 days. Participation in treatment trials for all patients with ATC was 34%. Conclusion: Since the implementation of FAST, the access time has decreased and the number of successful referrals for ATC has increased significantly.

KW - anaplastic thyroid carcinoma

KW - clinical trials

KW - multidisciplinary care

KW - quality improvement

KW - thyroid cancer

UR - http://www.scopus.com/inward/record.url?scp=85019000776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019000776&partnerID=8YFLogxK

U2 - 10.1002/hed.24784

DO - 10.1002/hed.24784

M3 - Article

C2 - 28452157

AN - SCOPUS:85019000776

SN - 1043-3074

VL - 39

SP - 1291

EP - 1295

JO - Head and Neck

JF - Head and Neck

IS - 7

ER -

Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this